Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Thursday, 9th May 2024 CLDX stock ended at $41.06. This is 0.364% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.12% from a day low at $41.01 to a day high of $41.88.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Oct 20, 2016 $49.80 $51.60 $49.50 $51.60 96 853
Oct 19, 2016 $54.30 $54.30 $49.65 $49.65 98 953
Oct 18, 2016 $51.75 $52.65 $51.15 $51.90 87 133
Oct 17, 2016 $51.75 $53.55 $50.25 $50.55 96 373
Oct 14, 2016 $55.05 $55.80 $51.60 $51.60 147 727
Oct 13, 2016 $55.65 $57.30 $54.15 $54.15 130 647
Oct 12, 2016 $58.50 $58.80 $56.55 $56.70 149 147
Oct 11, 2016 $63.00 $63.45 $57.45 $57.90 180 040
Oct 10, 2016 $63.90 $65.10 $62.25 $63.60 141 847
Oct 07, 2016 $63.15 $63.75 $61.35 $62.10 106 467
Oct 06, 2016 $65.85 $66.00 $62.70 $63.00 166 500
Oct 05, 2016 $65.10 $66.45 $64.05 $65.85 142 020
Oct 04, 2016 $64.95 $67.35 $63.15 $64.05 364 500
Oct 03, 2016 $60.15 $61.50 $58.80 $60.00 82 380
Sep 30, 2016 $57.45 $60.60 $56.70 $60.60 167 313
Sep 29, 2016 $60.00 $60.15 $57.00 $57.00 155 687
Sep 28, 2016 $65.40 $66.75 $57.90 $59.85 360 447
Sep 27, 2016 $57.00 $63.60 $56.70 $63.45 324 000
Sep 26, 2016 $57.15 $57.75 $56.55 $57.00 72 287
Sep 23, 2016 $55.65 $58.05 $55.35 $57.45 128 727
Sep 22, 2016 $56.10 $56.40 $54.30 $55.80 105 753
Sep 21, 2016 $55.80 $56.40 $53.70 $55.80 135 833
Sep 20, 2016 $55.65 $56.25 $54.60 $55.35 128 507
Sep 19, 2016 $55.20 $55.80 $54.45 $55.05 118 287
Sep 16, 2016 $54.45 $55.80 $54.00 $54.75 186 140
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT